LAB Reports 50% Increase First Quarter Net Profit

March 17, 2020

The Limners and Bards Limited (LAB), for the first quarter ended January 30, 2020, reported a 39% increase in operating revenues to $263 million versus $189.37 million booked in 2019.

Cost of operating revenue rose by 43% for the period to $172.72 million (2019: $121.17 million). Consequently, gross profit for the period rose by 32% closing at $90.28 million compared to $68.20 million for the same period last year.

The Company reported a 69% increase in administration expenses to $40.70 million (2019: $24.11 million). Also, selling and distribution costs for the quarter totaled $384,300 compared to $676,510 for the previous period. Therefore, total operating expenses amounted to $41.09 million, a 66% increase from the previous period which was $24.78 million. However, profit before net finance cost and taxation rose by 13% to $49.19 million (2019: $43.42 million).

Net finance costs went down to $145,332 (2019: $1.27 million). This was as a result of a surge in finance income to $1.22 million compared to $25,806 for the same quarter ended January 2019. Finance cost for the three months closed at $1.36 million (2019: $1.30 million).

Profit before taxation amounted to $48.91 million (2019: $42.14 million). There was no taxation booked for the period (2019: $9.58 million), as such net profit for the first quarter grew by 50% to $48.91 million (2019: $32.56 million).

Earnings per share (EPS) for the first quarter amounted to $0.05 compared to $0.03 for the corresponding quarter for the prior year. The trailing twelve month earnings per share amounted to $0.12. The number of shares used in our calculations is 945,690,252 units. Notably, LAB’s stock price closed the trading period on March 16, 2020 at a price of $2.03.

 

Balance Sheet Highlights: 

As at January 31, 2020, the Company reported total assets of $555.84 million, an 83% rise when compared to $304.45 million a year ago. This was as a result of ‘Accounts receivable’ and ‘Cash and cash equivalents’ which closed at $194.47 million (2019: $149.24 million) and $248.77 million (2019: $53.07 million), respectively.

Shareholders’ Equity as at January 31, 2020 was $386.06 million compared to $115.38 million a year ago. This resulted in a book value per share of $0.41 compared to $0.12 in 2019.

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein

2020-03-17T12:28:00-05:00